Related Experiment Video

Updated: Dec 14, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.6K

A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway

Mei-Hua Bao1,2, Qiao-Li Lv3, Hai-Gang Li1,2

  • 1Academician Workstation, Changsha Medical University, Changsha 410219, China.

Mediators of Inflammation
|July 23, 2020
PubMed
Abstract

Insights

TNK1 (TNK1) plays a role in atherosclerosis inflammation. Inhibiting TNK1 reduced inflammation and lipid buildup in cells, suggesting a mechanism involving the Tyk2/STAT pathway.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Atherosclerosis is a chronic inflammatory disease with significant clinical impact.
  • Understanding the molecular mechanisms underlying atherosclerosis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the anti-inflammatory functions of TNK1 in atherosclerosis.
  • To elucidate the underlying mechanisms of TNK1's role in this disease.

Main Methods:

  • Utilized ApoE(-/-) mice fed a high-fat diet and human carotid endarterectomy plaques to study TNK1 expression.
  • Employed THP-1 cells stimulated with oxidized low-density lipoprotein (oxLDL) to assess inflammatory responses and TNK1's effects.
  • Investigated the Tyk2/STAT signaling pathway to uncover TNK1's mechanism of action.

Main Results:

  • TNK1 expression was elevated in atherosclerotic lesions from both mice and humans.
  • Inhibition of TNK1 in THP-1 cells reduced oxLDL-induced secretion of inflammatory factors (IL-12, IL-6, TNF-α).
  • TNK1 suppression also decreased lipid uptake and cellular cholesterol content, and inhibited Tyk2/STAT phosphorylation.

Conclusions:

  • TNK1 is implicated in the inflammatory processes of atherosclerosis.
  • Inhibiting TNK1 demonstrates anti-inflammatory and lipid-lowering effects in cellular models.
  • The Tyk2/STAT signaling pathway is a potential mechanism through which TNK1 influences atherosclerosis.

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.2K
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.6K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
84.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
601
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K